Literature DB >> 10675335

Regulation of E2F1 activity by acetylation.

M A Martínez-Balbás1, U M Bauer, S J Nielsen, A Brehm, T Kouzarides.   

Abstract

During the G(1) phase of the cell cycle, an E2F-RB complex represses transcription, via the recruitment of histone deacetylase activity. Phosphorylation of RB at the G(1)/S boundary generates a pool of 'free' E2F, which then stimulates transcription of S-phase genes. Given that E2F1 activity is stimulated by p300/CBP acetylase and repressed by an RB-associated deacetylase, we asked if E2F1 was subject to modification by acetylation. We show that the p300/CBP-associated factor P/CAF, and to a lesser extent p300/CBP itself, can acetylate E2F1 in vitro and that intracellular E2F1 is acetylated. The acetylation sites lie adjacent to the E2F1 DNA-binding domain and involve lysine residues highly conserved in E2F1, 2 and 3. Acetylation by P/CAF has three functional consequences on E2F1 activity: increased DNA-binding ability, activation potential and protein half-life. These results suggest that acetylation stimulates the functions of the non-RB bound 'free' form of E2F1. Consistent with this, we find that the RB-associated histone deacetylase can deacetylate E2F1. These results identify acetylation as a novel regulatory modification that stimulates E2F1's activation functions.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10675335      PMCID: PMC305604          DOI: 10.1093/emboj/19.4.662

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  56 in total

1.  E2F: a link between the Rb tumor suppressor protein and viral oncoproteins.

Authors:  J R Nevins
Journal:  Science       Date:  1992-10-16       Impact factor: 47.728

2.  Expression cloning of a cDNA encoding a retinoblastoma-binding protein with E2F-like properties.

Authors:  W G Kaelin; W Krek; W R Sellers; J A DeCaprio; F Ajchenbaum; C S Fuchs; T Chittenden; Y Li; P J Farnham; M A Blanar
Journal:  Cell       Date:  1992-07-24       Impact factor: 41.582

3.  A cDNA encoding a pRB-binding protein with properties of the transcription factor E2F.

Authors:  K Helin; J A Lees; M Vidal; N Dyson; E Harlow; A Fattaey
Journal:  Cell       Date:  1992-07-24       Impact factor: 41.582

4.  E2F-1-mediated transactivation is inhibited by complex formation with the retinoblastoma susceptibility gene product.

Authors:  E K Flemington; S H Speck; W G Kaelin
Journal:  Proc Natl Acad Sci U S A       Date:  1993-08-01       Impact factor: 11.205

5.  Residues phosphorylated by TFIIH are required for E2F-1 degradation during S-phase.

Authors:  L Vandel; T Kouzarides
Journal:  EMBO J       Date:  1999-08-02       Impact factor: 11.598

6.  Independent binding of the retinoblastoma protein and p107 to the transcription factor E2F.

Authors:  L Cao; B Faha; M Dembski; L H Tsai; E Harlow; N Dyson
Journal:  Nature       Date:  1992-01-09       Impact factor: 49.962

7.  A new component of the transcription factor DRTF1/E2F.

Authors:  R Girling; J F Partridge; L R Bandara; N Burden; N F Totty; J J Hsuan; N B La Thangue
Journal:  Nature       Date:  1993-03-04       Impact factor: 49.962

8.  Expression of transcription factor E2F1 induces quiescent cells to enter S phase.

Authors:  D G Johnson; J K Schwarz; W D Cress; J R Nevins
Journal:  Nature       Date:  1993-09-23       Impact factor: 49.962

9.  Adenovirus E1a prevents the retinoblastoma gene product from repressing the activity of a cellular transcription factor.

Authors:  M Zamanian; N B La Thangue
Journal:  EMBO J       Date:  1992-07       Impact factor: 11.598

10.  A direct link between core histone acetylation and transcriptionally active chromatin.

Authors:  T R Hebbes; A W Thorne; C Crane-Robinson
Journal:  EMBO J       Date:  1988-05       Impact factor: 11.598

View more
  204 in total

1.  Antisense-mediated depletion of p300 in human cells leads to premature G1 exit and up-regulation of c-MYC.

Authors:  S Kolli; A M Buchmann; J Williams; S Weitzman; B Thimmapaya
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-10       Impact factor: 11.205

2.  p300/CBP-mediated p53 acetylation is commonly induced by p53-activating agents and inhibited by MDM2.

Authors:  A Ito; C H Lai; X Zhao; S Saito; M H Hamilton; E Appella; T P Yao
Journal:  EMBO J       Date:  2001-03-15       Impact factor: 11.598

3.  Acetylation of TAF(I)68, a subunit of TIF-IB/SL1, activates RNA polymerase I transcription.

Authors:  V Muth; S Nadaud; I Grummt; R Voit
Journal:  EMBO J       Date:  2001-03-15       Impact factor: 11.598

Review 4.  Acetylation: a regulatory modification to rival phosphorylation?

Authors:  T Kouzarides
Journal:  EMBO J       Date:  2000-03-15       Impact factor: 11.598

Review 5.  Chromatin modification and disease.

Authors:  C A Johnson
Journal:  J Med Genet       Date:  2000-12       Impact factor: 6.318

6.  Transcription factor Sp3 is regulated by acetylation.

Authors:  H Braun; R Koop; A Ertmer; S Nacht; G Suske
Journal:  Nucleic Acids Res       Date:  2001-12-15       Impact factor: 16.971

7.  Interaction between acetylated MyoD and the bromodomain of CBP and/or p300.

Authors:  A Polesskaya; I Naguibneva; A Duquet; E Bengal; P Robin; A Harel-Bellan
Journal:  Mol Cell Biol       Date:  2001-08       Impact factor: 4.272

8.  Dnmt3a binds deacetylases and is recruited by a sequence-specific repressor to silence transcription.

Authors:  F Fuks; W A Burgers; N Godin; M Kasai; T Kouzarides
Journal:  EMBO J       Date:  2001-05-15       Impact factor: 11.598

Review 9.  Acetylation of histones and transcription-related factors.

Authors:  D E Sterner; S L Berger
Journal:  Microbiol Mol Biol Rev       Date:  2000-06       Impact factor: 11.056

10.  Transactivation of E2F-regulated genes by polyomavirus large T antigen: evidence for a two-step mechanism.

Authors:  Maria Nemethova; Michael Smutny; Erhard Wintersberger
Journal:  Mol Cell Biol       Date:  2004-12       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.